Trials / Conditions / Epilepsy, Complex Partial

Epilepsy, Complex Partial

13 registered clinical trials studyying Epilepsy, Complex Partial.

Status	Trial	Sponsor	Phase
Completed	Neural Correlates of Cognition and Mood NCT04573569	University of Minnesota	—
Completed	Bioavailability, Safety, and Tolerability of BIS-001 ER NCT03156439	Supernus Pharmaceuticals, Inc.	Phase 1
Terminated	Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin NCT01128712	Northeast Regional Epilepsy Group	Phase 4
Completed	A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 NCT01002820	Marinus Pharmaceuticals	Phase 2
Completed	An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With NCT00744731	SK Life Science, Inc.	Phase 3
Completed	A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Parti NCT00740623	SK Life Science, Inc.	Phase 3
Completed	An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in P NCT00991757	SK Life Science, Inc.	Phase 3
Completed	A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. NCT00433667	SK Life Science, Inc.	Phase 3
Completed	A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. NCT00425282	SK Life Science, Inc.	Phase 3
Completed	Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Inte NCT00319501	Pfizer	Phase 3
Completed	Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy NCT00056576	Eisai Inc.	Phase 3
Completed	Pregabalin Open-Label Extension Trial in Patients With Partial Seizures NCT00143143	Pfizer	Phase 3
Completed	Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism NCT00001489	National Institute of Neurological Disorders and Stroke (NINDS)	—